Physician

Mark A Kleiner, MD

According to 2025 Medicare claims, Mark Kleiner, MD (NPI: 1982610184) practices family practice in the Lynchburg, VA market, with the plurality of this provider's patient population coming from Bedford, VA. This provider's primary affiliated billing organization is PRIVIA MEDICAL GROUP, LLC (NPI: 1013042480; TIN: 202265068) and primary practice location at 24551-2238. Kleiner is affiliated with the Privia Quality Network, LLC (ACO ID: A2057), participating under the MSSP model.

Kleiner's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 469 traditional Medicare patients, billed 10,345 HCPCS/CPT codes, and received $238,911 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 9,602 prescription claims across 650 beneficiaries totaling $859,450 in drug costs, led by Jardiance (Empagliflozin). DME data shows 508 claims. Open Payments data shows 84 records totaling $13,106. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $129,953 to $238,911. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $385,439 to $859,450. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $11,154 to $38,309.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	499	15,399	$129,953
2016	527	18,213	$166,742
2017	543	22,137	$187,022
2018	545	19,965	$197,772
2019	564	17,805	$204,045
2020	473	8,905	$205,891
2021	618	13,478	$247,189
2022	554	11,484	$246,725
2023	474	11,025	$220,406
2024	469	10,345	$238,911

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	398	6,167	$385,439
2016	460	6,766	$433,878
2017	459	6,768	$456,731
2018	520	6,870	$501,274
2019	516	6,598	$549,131
2020	502	6,996	$607,915
2021	550	7,640	$779,694
2022	599	8,173	$858,647
2023	620	8,796	$962,794
2024	650	9,602	$859,450

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	94	343	$10,898
2016	80	414	$10,893
2017	118	485	$10,787
2018	154	615	$15,991
2019	144	587	$14,056
2020	197	587	$19,507
2021	124	543	$27,726
2022	129	473	$30,052
2023	139	552	$41,244
2024	115	508	$36,026

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	303	303	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	381	612	$77
80061	Blood test, lipids (cholesterol and triglycerides)	298	381	$13
36415	Insertion of needle into vein for collection of blood sample	372	639	$9
80048	Blood test, basic group of blood chemicals (calcium, total)	265	366	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	86	6,024	$108,869
Eliquis	Apixaban	67	3,708	$71,120
Ozempic	Semaglutide	51	2,242	$66,007
Xarelto	Rivaroxaban	55	3,690	$63,499
Tresiba Flextouch U-200	Insulin Degludec	35	2,539	$48,157

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	12	54	$20,456
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	13	$2,541
A7033	Pillow for use on nasal cannula type interface, replacement only, pair	N	N/R	26	$1,793
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	15	32	$1,603
A7031	Face mask interface, replacement for full face mask, each	N	N/R	18	$1,502

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	81	$2,103	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$11,003	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark A. Kleiner, MD?

Tedicare shows public-source Medicare data for Mark A. Kleiner, MD (NPI 1982610184), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark A. Kleiner, MD have ACO affiliation data?

Mark A. Kleiner, MD is shown with ACO affiliation data for Privia Quality Network, LLC (MSSP, ACO ID A2057).

What billing organization is linked to Mark A. Kleiner, MD?

Mark A. Kleiner, MD is linked to PRIVIA MEDICAL GROUP, LLC (billing NPI 1013042480) in the available physician profile data.

Does Mark A. Kleiner, MD have Open Payments data?

Mark A. Kleiner, MD has 84 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.